Liver disease in pregnancy
The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Abstract
Severe liver disease in pregnancy is rare. Pregnancy-related liver disease is the most frequent cause of liver dysfunction in pregnancy and provides a real threat to fetal and maternal survival. A rapid diagnosis differentiating between liver disease related and unrelated to pregnancy is required in women who present with liver dysfunction during pregnancy. Research has improved our understanding of the pathogenesis of pregnancy-related liver disease, which has translated into improved maternal and fetal outcomes. Here, we provide an overview of liver diseases that occur in pregnancy, an update on the key mechanisms involved in their pathogenesis, and assessment of available treatment options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pregnancy in patients with advanced cirrhosis, as in other patients with advanced cirrhosis, is associated with maternal complications related to portal hypertension, increased maternal mortality and with adverse foetal outcome.442”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [442]
Citations
Cites
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055352 · Cited by 1,802
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
Sebire, N., Jolly, M., Harris, J., Wadsworth, J., Joffe, M., Beard, R., Regan, L., & Robinson, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801670 · Cited by 1,743
Weinstein, L. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32330-4 · Cited by 1,252
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
(2006) · New England Journal of Medicine · doi:10.1056/nejmx060063 · Cited by 1,235
Diagnosis and Management of Gestational Hypertension and Preeclampsia
Sibai, B. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00475-7 · Cited by 1,146
Sibai, B. M., Ramadan, M. K., Usta, I., Salama, M., Mercer, B. M., & Friedman, S. A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90043-i · Cited by 1,089
Glantz, A., Marschall, H.-U., & Mattsson, L.-Å. (2004) · Hepatology · doi:10.1002/hep.20336 · Cited by 844
Research works printed but not linked: 1
- Tandon, 1982, An epidemic of non-A, non-B hepatitis in north India, Indian J Med Res, 75, 739
Cited by
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Wikström Shemer, E., Marschall, H., Ludvigsson, J., & Stephansson, O. (2013) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12174 · Cited by 299
Westbrook, R. H., Dusheiko, G., & Williamson, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.030 · Cited by 264
“[1-3] A rapid evaluation to distinguish them”
Self-citationDarrow, L. A., Stein, C. R., & Steenland, K. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1206372 · Cited by 238
Metadata
- Authors
- Joshi, D., James, A., Quaglia, A., Westbrook, R. H., & Heneghan, M. A.
- Affiliations
- King's College Hospital (GB)
- Corresponding author
- Heneghan, Michael A
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 375
- Issue
- 9714
- Pages
- 594-605
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2058864990
- Cited by
- 385
- References
- 112
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 9 · 2023: 21 · 2022: 22 · 2021: 31 · 2020: 25 · 2019: 28 · 2018: 23 · 2017: 22 · 2016: 27 · 2015: 39 · 2014: 24 · 2013: 26 · 2012: 30
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- pregnancy-related liver disease, pathogenesis, maternal outcomes, fetal outcomes, diagnosis, treatment options, hepatotoxicity
- MeSH terms
- Cholestasis, Intrahepatic, Eclampsia, Fatty Liver, Female, Humans, Hyperemesis Gravidarum, Liver Diseases, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Prognosis, Risk Factors, Liver Transplantation, HELLP Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liver disease in pregnancy. https://app.cochat.ai/papers/10.1016/s0140-6736(09)61495-1
- The paper
- Joshi, D., James, A., Quaglia, A., Westbrook, R. H., & Heneghan, M. A. (2010). Liver disease in pregnancy. The Lancet. https://doi.org/10.1016/s0140-6736(09)61495-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.